Hot Features
プレミアム
Labcorp Holdings Inc (0JSY)
LSE
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Mr. Adam H. SchechterPresident, CEO & Chairman | -5.90k | 1.50M | Automatic Disposition | 254.50 | 107.23k | -5.22% |
| 2026-03-26 | Mr. Adam H. SchechterPresident, CEO & Chairman | -26.11k | 7.01M | Sale to Issuer | 268.38 | 113.14k | -18.75% |
| 2026-03-26 | Ms. Anita Z. GrahamExec. VP & Chief HR Officer | -2.88k | 772.67k | Sale to Issuer | 268.38 | 5.19k | -35.70% |
| 2026-03-26 | Mr. Mark S. Schroederインサイダー | -6.07k | 1.63M | Sale to Issuer | 268.38 | 12.68k | -32.37% |
| 2026-03-26 | Dr. Brian J. CaveneyEVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | -4.91k | 1.32M | Sale to Issuer | 268.38 | 36.49k | -11.85% |
| 2026-03-27 | Mr. Peter J. WilkinsonSenior VP & CAO | -1.63k | 436.09k | Automatic Disposition | 267.05 | 1.85k | -46.86% |
| 2026-03-26 | Mr. Peter J. WilkinsonSenior VP & CAO | -755.00 | 202.63k | Sale to Issuer | 268.38 | 1.85k | -28.96% |
| 2026-03-26 | Mr. Bryan T. VaughnEVP & President of Diagnostics | -451.00 | 121.04k | Sale to Issuer | 268.38 | 6.75k | -6.27% |
| 2026-03-26 | Ms. Sandra D. van der Vaartインサイダー | -2.72k | 730.53k | Sale to Issuer | 268.38 | 6.24k | -30.38% |
| 2026-03-26 | Ms. Amy B. SummyEVP, CMO & Consumer Health Lead | -1.84k | 492.75k | Sale to Issuer | 268.38 | 7.88k | -18.90% |
| 2026-03-26 | Mr. Akinbolade OyegunwaExec. VP and Chief Information & Technology Officer | -382.00 | 102.52k | Sale to Issuer | 268.38 | 5.06k | -7.01% |
| 2026-03-27 | Mr. Jonathan C. MeltzerEVP & Chief Operations Officer | -839.00 | 224.05k | Automatic Disposition | 267.05 | 3.62k | -18.82% |
| 2026-03-26 | Mr. Jonathan C. MeltzerEVP & Chief Operations Officer | -711.00 | 190.82k | Sale to Issuer | 268.38 | 3.62k | -16.42% |
| 2026-03-26 | Ms. Kathryn Wright KyleExec. VP, Chief Legal Officer and Corporate Secretary | -451.00 | 121.04k | Sale to Issuer | 268.38 | 4.58k | -8.97% |
| 2026-03-26 | Ms. Megan D. BaileyExec. VP and President of Central Laboratory Services & International Labcorp | -481.00 | 129.09k | Sale to Issuer | 268.38 | 4.85k | -9.02% |
| 2026-03-03 | Mr. Adam H. SchechterPresident, CEO & Chairman | -8.71k | 2.44M | 売り | 279.96 | 80.77k | -9.73% |
| 2026-02-27 | Ms. Sandra D. van der Vaartインサイダー | -547.54 | 156.00k | 売り | 284.91 | 2.58k | -17.51% |
| 2026-02-24 | Dr. Brian J. CaveneyEVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | -1.50k | 429.46k | 売り | 286.31 | 30.11k | -4.75% |
| 2026-02-19 | Mr. Peter J. WilkinsonSenior VP & CAO | -666.00 | 185.11k | Automatic Disposition | 277.94 | 1.85k | -26.45% |
| 2026-02-11 | Ms. Amy B. SummyEVP, CMO & Consumer Health Lead | 147.00 | 0.00 | Derivative Exercise and Retained Stock | - | 5.72k | 2.64% |
| 2026-02-11 | Ms. Amy B. SummyEVP, CMO & Consumer Health Lead | -83.00 | 24.06k | Derivative Exercise and Sale | 289.89 | 5.72k | - |
| 2026-02-11 | Mr. Peter J. WilkinsonSenior VP & CAO | 490.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.52k | 24.16% |
| 2026-02-11 | Mr. Peter J. WilkinsonSenior VP & CAO | -206.00 | 59.72k | Derivative Exercise and Sale | 289.89 | 2.52k | - |
| 2026-02-11 | Ms. Julia A. WangCFO & Exec. VP | 615.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.82k | 51.16% |
| 2026-02-11 | Ms. Julia A. WangCFO & Exec. VP | -245.00 | 71.02k | Derivative Exercise and Sale | 289.89 | 1.82k | - |
| 2026-02-11 | Ms. Sandra D. van der Vaartインサイダー | 277.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.13k | 9.72% |
| 2026-02-11 | Ms. Sandra D. van der Vaartインサイダー | -99.00 | 28.70k | Derivative Exercise and Sale | 289.89 | 3.13k | - |
| 2026-02-11 | Mr. Bryan T. VaughnEVP & President of Diagnostics | 230.00 | 0.00 | Derivative Exercise and Retained Stock | - | 5.61k | 4.27% |
| 2026-02-11 | Mr. Bryan T. VaughnEVP & President of Diagnostics | -93.00 | 26.96k | Derivative Exercise and Sale | 289.89 | 5.61k | - |
| 2026-02-11 | Mr. Mark S. Schroederインサイダー | 547.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.47k | 9.23% |
| 2026-02-11 | Mr. Mark S. Schroederインサイダー | -259.00 | 75.08k | Derivative Exercise and Sale | 289.89 | 6.47k | - |
| 2026-02-11 | Mr. Adam H. SchechterPresident, CEO & Chairman | 2.14k | 0.00 | Derivative Exercise and Retained Stock | - | 89.48k | 2.44% |
| 2026-02-11 | Mr. Adam H. SchechterPresident, CEO & Chairman | -1.52k | 440.92k | Derivative Exercise and Sale | 289.89 | 89.48k | - |
| 2026-02-11 | Mr. Adam H. SchechterPresident, CEO & Chairman | -5.27k | 1.50M | Automatic Disposition | 284.38 | 89.48k | -5.57% |
| 2026-02-11 | Mr. Akinbolade OyegunwaExec. VP and Chief Information & Technology Officer | 162.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.11k | 4.11% |
| 2026-02-11 | Mr. Akinbolade OyegunwaExec. VP and Chief Information & Technology Officer | -68.00 | 19.71k | Derivative Exercise and Sale | 289.89 | 4.11k | - |
| 2026-02-11 | Ms. Kathryn Wright KyleExec. VP, Chief Legal Officer and Corporate Secretary | 154.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.44k | 4.68% |
| 2026-02-11 | Ms. Kathryn Wright KyleExec. VP, Chief Legal Officer and Corporate Secretary | -62.00 | 17.97k | Derivative Exercise and Sale | 289.89 | 3.44k | - |
| 2026-02-11 | Mr. Jonathan C. MeltzerEVP & Chief Operations Officer | 86.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.78k | 3.19% |
| 2026-02-11 | Mr. Jonathan C. MeltzerEVP & Chief Operations Officer | -157.00 | 45.56k | Derivative Exercise and Sale | 289.89 - 290.42 | 2.78k | - |
| 2026-02-11 | Ms. Anita Z. GrahamExec. VP & Chief HR Officer | 247.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.46k | 20.36% |
| 2026-02-11 | Ms. Anita Z. GrahamExec. VP & Chief HR Officer | -109.00 | 31.60k | Derivative Exercise and Sale | 289.89 | 1.46k | - |
| 2026-02-11 | Dr. Brian J. CaveneyEVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | 529.00 | 0.00 | Derivative Exercise and Retained Stock | - | 31.61k | 1.70% |
| 2026-02-11 | Dr. Brian J. CaveneyEVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | -211.00 | 61.17k | Derivative Exercise and Sale | 289.89 | 31.61k | - |
| 2026-02-11 | Ms. Megan D. BaileyExec. VP and President of Central Laboratory Services & International Labcorp | 265.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.15k | 6.82% |
| 2026-02-11 | Ms. Megan D. BaileyExec. VP and President of Central Laboratory Services & International Labcorp | -138.00 | 40.00k | Derivative Exercise and Sale | 289.89 | 4.15k | - |
| 2026-02-11 | Dr. Paul B. RothmanIndependent Director | 897.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.57k | 53.58% |
| 2026-02-11 | Ms. Kathryn E. WengelIndependent Director | 897.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.13k | 27.72% |
| 2026-02-11 | Ms. Richelle P. ParhamIndependent Director | 897.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.37k | 36.33% |
| 2026-02-11 | Mr. Peter M. NeupertIndependent Director | 897.00 | 0.00 | Derivative Exercise and Retained Stock | - | 13.78k | 6.96% |
| 2026-02-11 | Dr. Garheng Albert KongVice Chair & Lead Independent Director | 897.00 | 0.00 | Derivative Exercise and Retained Stock | - | 13.74k | 6.98% |
| 2026-02-11 | Ms. Kirsten Marie KliphouseIndependent Director | 897.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.16k | 39.64% |
| 2026-02-11 | Mr. Jeffrey A. DavisIndependent Director | 897.00 | 0.00 | Derivative Exercise and Retained Stock | - | 5.46k | 19.66% |
| 2026-02-11 | Ms. Kerrii B. AndersonIndependent Director | 897.00 | 0.00 | Derivative Exercise and Retained Stock | - | 9.85k | 10.02% |
| 2026-02-10 | Mr. Jonathan C. MeltzerEVP & Chief Operations Officer | -91.00 | 25.19k | Automatic Disposition | 276.79 | 2.70k | -3.27% |
| 2026-02-06 | Ms. Julia A. WangCFO & Exec. VP | 639.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.20k | 113.50% |
| 2026-02-06 | Ms. Julia A. WangCFO & Exec. VP | -254.00 | 70.41k | Derivative Exercise and Sale | 277.20 | 1.20k | - |
| 2026-02-06 | Dr. Brian J. CaveneyEVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | 909.00 | 0.00 | Derivative Exercise and Retained Stock | - | 31.08k | 3.01% |
| 2026-02-06 | Dr. Brian J. CaveneyEVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | -389.00 | 107.26k | Derivative Exercise and Sale | 274.01 - 277.20 | 31.08k | - |
| 2026-02-06 | Mr. Akinbolade OyegunwaExec. VP and Chief Information & Technology Officer | 217.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.94k | 5.82% |
| 2026-02-06 | Mr. Akinbolade OyegunwaExec. VP and Chief Information & Technology Officer | -112.00 | 30.88k | Derivative Exercise and Sale | 274.01 - 277.20 | 3.94k | - |
| 2026-02-06 | Mr. Adam H. SchechterPresident, CEO & Chairman | 5.04k | 0.00 | Derivative Exercise and Retained Stock | - | 92.62k | 5.76% |
| 2026-02-06 | Mr. Adam H. SchechterPresident, CEO & Chairman | -2.67k | 734.98k | Derivative Exercise and Sale | 274.01 - 277.20 | 92.62k | - |
| 2026-02-06 | Mr. Peter J. WilkinsonSenior VP & CAO | 176.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.03k | 9.50% |
| 2026-02-06 | Mr. Peter J. WilkinsonSenior VP & CAO | -91.00 | 25.08k | Derivative Exercise and Sale | 274.01 - 277.20 | 2.03k | - |
| 2026-02-06 | Mr. Mark S. Schroederインサイダー | 966.00 | 0.00 | Derivative Exercise and Retained Stock | - | 5.93k | 19.48% |
| 2026-02-06 | Mr. Mark S. Schroederインサイダー | -458.00 | 126.26k | Derivative Exercise and Sale | 274.01 - 277.20 | 5.93k | - |
| 2026-02-06 | Ms. Sandra D. van der Vaartインサイダー | 546.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.85k | 23.71% |
| 2026-02-06 | Ms. Sandra D. van der Vaartインサイダー | -194.00 | 53.48k | Derivative Exercise and Sale | 274.01 - 277.20 | 2.85k | - |
| 2026-02-06 | Mr. Bryan T. VaughnEVP & President of Diagnostics | 236.00 | 0.00 | Derivative Exercise and Retained Stock | - | 5.38k | 4.59% |
| 2026-02-06 | Mr. Bryan T. VaughnEVP & President of Diagnostics | -122.00 | 33.62k | Derivative Exercise and Sale | 274.01 - 277.20 | 5.38k | - |
| 2026-02-06 | Mr. Jonathan C. MeltzerEVP & Chief Operations Officer | 269.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.79k | 10.68% |
| 2026-02-06 | Mr. Jonathan C. MeltzerEVP & Chief Operations Officer | -261.00 | 71.94k | Derivative Exercise and Sale | 274.01 - 277.20 | 2.79k | - |
| 2026-02-06 | Ms. Kathryn Wright KyleExec. VP, Chief Legal Officer and Corporate Secretary | 236.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.29k | 7.73% |
| 2026-02-06 | Ms. Kathryn Wright KyleExec. VP, Chief Legal Officer and Corporate Secretary | -122.00 | 33.62k | Derivative Exercise and Sale | 274.01 - 277.20 | 3.29k | - |
| 2026-02-06 | Ms. Anita Z. GrahamExec. VP & Chief HR Officer | 463.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.21k | 61.73% |
| 2026-02-06 | Ms. Anita Z. GrahamExec. VP & Chief HR Officer | -231.00 | 63.68k | Derivative Exercise and Sale | 274.01 - 277.20 | 1.21k | - |
| 2026-02-06 | Ms. Amy B. SummyEVP, CMO & Consumer Health Lead | 273.00 | 0.00 | Derivative Exercise and Retained Stock | - | 5.58k | 5.15% |
| 2026-02-06 | Ms. Amy B. SummyEVP, CMO & Consumer Health Lead | -172.00 | 47.42k | Derivative Exercise and Sale | 274.01 - 277.20 | 5.58k | - |
| 2026-02-06 | Ms. Megan D. BaileyExec. VP and President of Central Laboratory Services & International Labcorp | 289.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.88k | 8.04% |
| 2026-02-06 | Ms. Megan D. BaileyExec. VP and President of Central Laboratory Services & International Labcorp | -180.00 | 49.55k | Derivative Exercise and Sale | 274.01 - 277.20 | 3.88k | - |
| 2025-11-11 | Mr. Adam H. SchechterPresident, CEO & Chairman | -5.75k | 1.51M | Automatic Disposition | 262.75 | 87.57k | -6.16% |
| 2025-11-01 | Ms. Megan D. BaileyExec. VP and President of Central Laboratory Services & International Labcorp | 191.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.59k | 5.61% |
| 2025-11-01 | Ms. Megan D. BaileyExec. VP and President of Central Laboratory Services & International Labcorp | -179.00 | 46.15k | Derivative Exercise and Sale | 257.84 | 3.59k | - |
| 2025-11-01 | Mr. Akinbolade OyegunwaExec. VP and Chief Information & Technology Officer | 263.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.73k | 7.59% |
| 2025-11-01 | Mr. Akinbolade OyegunwaExec. VP and Chief Information & Technology Officer | -107.00 | 27.59k | Derivative Exercise and Sale | 257.84 | 3.73k | - |
| 2025-10-31 | Ms. Richelle P. ParhamIndependent Director | -7.01k | 1.78M | 売り | 254.28 | 2.47k | -73.95% |
| 2025-08-13 | Ms. Sandra D. van der Vaartインサイダー | -3.90k | 546.40k | Derivative Exercise and Sale | 131.43 - 271.42 | 2.27k | - |
| 2025-08-11 | Mr. Adam H. SchechterPresident, CEO & Chairman | -5.64k | 1.51M | Automatic Disposition | 266.78 | 93.32k | -5.70% |
| 2025-07-30 | Dr. D. Gary Gillilandインサイダー | -2.00k | 529.90k | 売り | 264.95 | 6.66k | -23.11% |
| 2025-07-29 | Mr. Peter J. WilkinsonSenior VP & CAO | -202.00 | 52.73k | 売り | 261.01 - 261.04 | 1.85k | -9.83% |
| 2025-07-24 | Ms. Kerrii B. AndersonIndependent Director | -3.50k | 980.00k | Automatic Disposition | 280.00 | 8.95k | -28.10% |
| 2025-07-01 | Ms. Kerrii B. AndersonIndependent Director | -500.00 | 132.50k | Automatic Disposition | 265.00 | 12.45k | -3.86% |
| 2025-06-11 | Ms. Kerrii B. AndersonIndependent Director | -500.00 | 130.00k | Automatic Disposition | 260.00 | 12.95k | -3.72% |
| 2025-06-03 | Dr. Brian J. CaveneyEVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | -2.00k | 494.00k | 売り | 247.00 | 30.07k | -6.24% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
